
Maria Luisa Sulis, MD, MS
Pediatric Hematologist-Oncologist
Titles
Chief, Pediatric Hematologic Malignancies Service
Clinical Expertise
Pediatric Acute and Chronic Leukemias; Pediatric Lymphoma; Histiocytosis; Precision Medicine in Pediatric Oncology
We post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
New Patient Appointments
Scheduling a visit is easy. Click below or call us to get started.
Dr. Sulis accepts the following list of insurance providers. Select your insurance provider to see more details.
Payor Type: Commercial
In Network Coverage Type(s): HMO, EPO PPO, POS, Transplant
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO
Payor Type: Commercial
In Network Coverage Type(s): HMO, PPO
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, EPO, HMO
Payor Type: Commercial
In Network Coverage Type(s): HMO, EPO PPO, POS
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Commercial
In Network Coverage Type(s): Supplemental
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, HMO
Payor Type: Commercial
In Network Coverage Type(s): POS, EPO, HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, EPO, HMO
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO, HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO, HMO, DSN
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO
Payor Type: Commercial
In Network Coverage Type(s): HMO, EPO
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO
Payor Type: Commercial
In Network Coverage Type(s): EPO, HMO, PPO, POS
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): HMO, PPO
Payor Type: Commercial
In Network Coverage Type(s): PPO EPO
Payor Type: Commercial
In Network Coverage Type(s): HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO
Payor Type: Commercial
In Network Coverage Type(s): EPO
Payor Type: Commercial
In Network Coverage Type(s): EPO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO, HMO
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): State Government
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, EPO
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): State Government
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): State Government
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): Federal Government
Payor Type: Commercial
In Network Coverage Type(s): Supplemental
Payor Type: Commercial
In Network Coverage Type(s): PPO/OAP
Payor Type: Other
In Network Coverage Type(s): PPO, POS, EPO, HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): TBD
Payor Type: Commercial
In Network Coverage Type(s): HMO/EPO
Payor Type: Commercial
In Network Coverage Type(s): PPO, EPO
Payor Type: Commercial
In Network Coverage Type(s): State Government
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO, HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, HMO
Contact and Location
- 212-639-5175 Office Phone
- Speaks English, Italian, and Spanish

Memorial Sloan Kettering has locations throughout New York City, Long Island, New Jersey, and Westchester. These locations offer many services, including screening, chemotherapy, and medical testing.
See all locationsAbout Me
Education
MD, University of Cagliari, Italy
Residencies
Pediatrics - St. Vincent's Hospital and Medical Center, New York Medical College
Fellowships
Pediatric Hematology and Oncology - NewYork-Presbyterian/Columbia University Medical Center
Board Certifications
Pediatrics; Pediatric Hematology-Oncology
As a pediatric oncologist on the MSK Kids team, I am privileged to care for children with blood cancer. Most children with blood cancer today are cured, thanks to decades of collaboration among children’s cancer specialists around the world. However, the cure rate for children with cancer that does not respond to conventional therapy is still too low.
My research focuses on acute leukemia resistant to conventional therapies. My colleagues and I hope to use the advances we make in our understanding of the biology of leukemia and how patients respond to therapy to improve the effectiveness of children’s cancer treatment. I enjoy working closely with laboratory scientists, hematopathologists, and bioinformaticians. I strongly believe in two-way interaction. By bringing challenging questions to the laboratory, and making new diagnostic and treatment discoveries, we can cure more children with blood cancer while limiting the side effects of therapy.
Read more
I work closely with investigators in the Children’s Oncology Group (COG) and other collaborative groups to design clinical trials of new treatments for children with high-risk disease. For COG, I develop studies for children with newly diagnosed and relapsed T cell acute lymphoblastic leukemia. We study how to prevent a relapse of acute myeloid leukemia after a stem cell transplant.
Within MSK Kids, I oversee the clinical program for children with blood disorders. I work with an experienced and talented group of doctors, nurses, nurse practitioners, child life specialists, care coordinators, and social workers. Together, we give all the children we care for and their families the most comprehensive care. We strive to understand each child’s cancer as much as we can, to tailor therapy to their needs, to predict the risk of the cancer coming back, and to counsel families who may have an inherited risk of developing cancer. We work to support each child and family through their journey. We want to make a difficult and frightening experience as bearable as possible. At the end of the day, we are only successful if every patient and family feel they have received the best care.
At the end of the day, we are only successful if every patient and family feel they have received the best care.
-Dr. Sulis
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Clinical Trials
- Clinical Trials Investigated by Dr. Sulis
- A Phase 3 Study of Standard Chemotherapy with or without Venetoclax in Children and Adolescents with Relapsed Acute Myeloid Leukemia
- Clinical Trials Co-Investigated by Dr. Sulis
- A Phase 3 Study of Inotuzumab Ozogamicin and Standard Chemotherapy for Newly Diagnosed High-Risk B-Cell Acute Lymphocytic Leukemia, Mixed Acute Leukemia, and Disseminated B-LLy
- A Phase I Study Assessing the Combination of Immunotherapy and Targeted Chemotherapy to Treat Relapsed or Persistent Hodgkin Lymphoma
- A Phase I Study of Everolimus plus Standard Chemotherapy for Patients with T-Cell Lymphoblastic Leukemia or Lymphoma
Read more
- A Phase I Study of Idasanutlin Alone or with Chemotherapy in Pediatric and Young Adult Patients with Recurrent or Persistent Solid Tumors
- A Phase I Study of MRX-2843 in Adolescents and Young Adults with Recurrent or Persistent Acute Leukemias
- Stopping Tyrosine Kinase Inhibitor Treatment in Pediatric and Young Adult Patients with Chronic Myeloid Leukemia in Molecular Remission

Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
Visit PubMed for a full listing of Dr. Sulis’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
See all on PubMedPatient Reviews
At MSK, we’re committed to delivering the best care to every patient. We use feedback from our patients to continue to improve our care. We also post patient reviews online to help you make healthcare choices. Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Maria Luisa Sulis discloses the following relationships and financial interests:
No disclosures meeting criteria for time period
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2021 through disclosure submission in spring 2022). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].